Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩35.87T | 70x | 62.04 | ₩161,600 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38% Upside | Upgrade to Pro+ | |
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.48T | -226.2x | 9.01 | ₩196,200 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.08T | 171x | 1.18 | ₩113,200 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.1% Upside | Upgrade to Pro+ | |
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.82T | -53.5x | 0.66 | ₩80,600 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.7% Downside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.17T | ₩39,050 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.78T | -45.3x | 16.7 | ₩99,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.53T | 141x | 0.36 | ₩34,100 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.4% Upside | Upgrade to Pro+ | |
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.28T | ₩21,500 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩942.29B | -20.8x | 0.22 | ₩46,600 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩518.39B | -40.5x | 5.24 | ₩31,750 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩453.07B | -16.1x | -4.45 | ₩3,285 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩414.26B | -20.5x | 0.26 | ₩16,260 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩411.8B | -12.1x | ₩29,650 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩394.91B | ₩17,830 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩348.83B | -4.8x | 0 | ₩10,340 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩314.94B | -30.1x | -1.24 | ₩13,130 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩309.13B | -25.3x | ₩27,450 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩265.98B | 37.6x | 0.35 | ₩31,500 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onconic Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩246.45B | -1.3x | ₩21,850 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
JS Link | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩245.5B | -12.9x | 0.08 | ₩9,350 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩234.2B | ₩10,150 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩229.98B | -5.8x | -0.17 | ₩3,045 | 12.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩229.22B | -3.5x | ₩5,110 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
3Billion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩221.73B | ₩7,200 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩211.32B | -4.9x | 0.12 | ₩3,865 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩209.14B | -7x | 0.06 | ₩7,820 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.49B | -20.6x | -0.35 | ₩15,880 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tiumbio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩168.67B | -7.6x | 0.54 | ₩6,230 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OnCoCross | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩162.51B | -20.9x | 1.74 | ₩13,650 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prestige Biopharma | Seoul | Healthcare | Biotechnology & Medical Research | ₩154.45B | 36.7x | -0.16 | ₩12,740 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HEM Pharma | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩153.92B | ₩21,700 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩146.34B | -2.8x | 0.1 | ₩4,845 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellid | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩144.56B | ₩7,240 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ENCell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩144B | ₩13,220 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩140.19B | -8.4x | -0.13 | ₩4,000 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩137.05B | -34.6x | -0.63 | ₩4,420 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩135.41B | -16.5x | 0.1 | ₩1,592 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CJ Bioscience | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩130B | -3.3x | 0.75 | ₩9,970 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neoimmunetech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩123.09B | -0.03 | ₩1,240 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kang Stem Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩116.87B | -10.6x | -0.15 | ₩1,771 | -15.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orientbio | Seoul | Healthcare | Biotechnology & Medical Research | ₩107.66B | -26.4x | ₩910 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Shaperon | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩106.71B | -7.9x | -0.31 | ₩3,540 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dx Vx | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩105.82B | -2x | 0.29 | ₩2,150 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Panagene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩103.35B | -33.1x | ₩2,320 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
GL Pharm Tech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩98.9B | -146.2x | -1.65 | ₩1,289 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cytogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩94.82B | -5.5x | -1.1 | ₩3,975 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noul | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩91.81B | -3.8x | 0.16 | ₩2,480 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cell Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩90.75B | 6.3x | 0.06 | ₩13,290 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharos IBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩90.1B | -8.1x | 2.1 | ₩6,930 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genome | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩88.9B | -4.5x | -0.07 | ₩2,910 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |